Schwaneke Jeffrey A.'s Form 4/A amendment
Amendedagilon health, inc. (AGL) · filed Apr 3, 2025
- Accession no.
- 0001628280-25-016684
- Filed
- Apr 3, 2025
- Trade date
- Nov 29, 2023-Apr 1, 2025
- Filing delay
- 491 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Nov 30, 2023
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $250.2K. It was filed 491 days after the trade.
This amendment replaces 0001628280-23-040361 (filed Nov 30, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schwaneke Jeffrey A.CIK 0001446919 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2023 | Common Stock | PPurchaseAcquired | +22,300 | $11.22 | +$250,206 | 22,300 | Indirect | |
| Apr 1, 2025 | Common Stock | AGrant or awardAcquired | +428,922 | $0.00 | $0 | 1,130,552 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | Common Stock | AGrant or awardAcquired | +673,077 | $0.00 | $0 | 673,077 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.